Publications – Page 4 – KalVista Pharmaceuticals

Showing 31-38 out of 38

Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey

Jones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M

HAEA National Summit 2023

Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks

Grumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T

EAACI 2023

Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxis

Betschel S, van Kooten S, Heckmann M, Danese S, Caballero T

EAACI 2023

Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacks

Valerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H

EAACI 2023

HAE Patients Decision to Carry On-demand Treatment When Away from Home

Betschel S, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M

C1 Inhibitor Workshop 2023

Route of Administration Preferences of People with Hereditary Angioedema for On-demand Treatment: A US-based Qualitative Study

Desai V, Ledia Goga L, Czado S, Brown M, Myers K, Bukstein D, Audhya PK, Bouillet L

C1 Inhibitor Workshop 2023

Anxiety Associated With Parenteral On-demand Treatment For Hereditary Angioedema (HAE)

Burnette A, Anderson J, Longhurst H, van Kooten S, Heckmann M, Danese S, Goga L

AAAAI 2023

Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns

Riedl MA, Danese M, Danese S, Ulloa J, Maetzel A, Audhya PK

J Allergy Clin Immunol Pract

About

Science

Pipeline

Careers

Contact